HIG2 and URLC10 epitope peptide and vaccines containing the same

Details for Australian Patent Application No. 2009283763 (hide)

Owner Oncotherapy Science, Inc.

Inventors Tsunoda, Takuya; Ohsawa, Ryuji; Yoshimura, Sachiko

Agent Davies Collison Cave

Pub. Number AU-A-2009283763

PCT Pub. Number WO2010/021112

Priority 61/089,972 19.08.08 US

Filing date 14 August 2009

Wipo publication date 25 February 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

3 March 2011 PCT application entered the National Phase

  PCT publication WO2010/021112 Priority application(s): WO2010/021112

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009283776-Direct evaporative heat exchangers, methods of manufacture thereof and applications thereof to multi-stage cooling systems

2009283762-INHBB epitope peptides and vaccines containing the same